Literature DB >> 34615984

Updates in grading and invasion assessment in lung adenocarcinoma.

Alain C Borczuk1.   

Abstract

The pathologic evaluation of lung adenocarcinoma, because of greater understanding of disease progression and prognosis, has become more complex. It is clear that histologic growth patterns reflect indolent and aggressive disease, resulting in clearer morphologic groups that can be the underpinning of a grading system. In addition, the progression of adenocarcinoma from a tumor that preserves alveolar architecture to one that remodels and effaces lung structure has led to criteria that reflect invasive rather than in-situ growth. While some of these are based on tumor cell growth pattern, aspects of this remodeling from desmoplasia to artifacts of lung collapse and sectioning, can lead to difficult to interpret patterns with lower reproducibility between observers. Such scenarios are examined to provide updates on new histologic concepts and to highlight ongoing problem areas.
© 2021. The Author(s), under exclusive licence to United States & Canadian Academy of Pathology.

Entities:  

Mesh:

Year:  2021        PMID: 34615984     DOI: 10.1038/s41379-021-00934-3

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  1 in total

1.  RS1 gene is a novel prognostic biomarker for lung adenocarcinoma.

Authors:  Tao Zhang; Guowei Cheng; Ping Chen; Yue Peng; Lei Liu; Runze Li; Bin Qiu
Journal:  Thorac Cancer       Date:  2022-05-15       Impact factor: 3.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.